New drug combo aims to beat tough leukemia

NCT ID NCT07211958

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This phase 3 trial tests whether adding the drug revumenib to standard intensive chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) that has a specific genetic change (NPM1 mutation). About 468 participants will receive either revumenib or a placebo along with chemotherapy. The study looks at how long people live without their cancer getting worse and if the cancer becomes undetectable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
revumenib
What this could lead to
If it works, this could lead to a new treatment option that improves survival and reduces cancer cells for people with this type of AML.
What could go wrong
This is a large phase 3 trial, but it's still experimental. Adding revumenib may not improve outcomes and could cause additional side effects. Results are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA WITH NPM1 MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Clinical Trial Site

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • Clinical Trial Site

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

  • Clinical Trial Site

    RECRUITING

    Perth, Western Australia, 6000, Australia

  • Clinical Trial Site

    RECRUITING

    Gosford, 2250, Australia

  • Clinical Trial Site

    RECRUITING

    Wollongong, 2500, Australia

  • Clinical Trial Site

    RECRUITING

    Sankt Pölten, Lower Austria, 3100, Austria

  • Clinical Trial Site

    RECRUITING

    Graz, Styria, 8036, Austria

  • Clinical Trial Site

    RECRUITING

    Leoben, Styria, 8700, Austria

  • Clinical Trial Site

    RECRUITING

    Linz, 4030, Austria

  • Clinical Trial Site

    RECRUITING

    Ghent, 9000, Belgium

  • Clinical Trial Site

    RECRUITING

    Fortaleza, Paraná, 60430-372, Brazil

  • Clinical Trial Site

    RECRUITING

    Barretos, São Paulo, 14784-400, Brazil

  • Clinical Trial Site

    RECRUITING

    Jaú, 17210-080, Brazil

  • Clinical Trial Site

    RECRUITING

    Porto Alegre, 90610-910, Brazil

  • Clinical Trial Site

    RECRUITING

    Montreal, H1T 2M4, Canada

  • Clinical Trial Site

    RECRUITING

    Toronto, M5G 2C1, Canada

  • Clinical Trial Site

    RECRUITING

    Angers, Loire-Atlantique, 44093, France

  • Clinical Trial Site

    RECRUITING

    Bayonne, 64100, France

  • Clinical Trial Site

    RECRUITING

    Bordeaux, 33000, France

  • Clinical Trial Site

    RECRUITING

    Batumi, Adjara, 6000, Georgia

  • Clinical Trial Site

    RECRUITING

    Tbilisi, 0112, Georgia

  • Clinical Trial Site

    RECRUITING

    Tbilisi, 0186, Georgia

  • Clinical Trial Site

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Clinical Trial Site

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40479, Germany

  • Clinical Trial Site

    RECRUITING

    Herne, North Rhine-Westphalia, 44625, Germany

  • Clinical Trial Site

    RECRUITING

    Jena, Thuringia, 07747, Germany

  • Clinical Trial Site

    RECRUITING

    Hamburg, 20251, Germany

  • Clinical Trial Site

    RECRUITING

    Győr, Gyor-Moson-Sopron Varmegye, H-9024, Hungary

  • Clinical Trial Site

    RECRUITING

    Petah Tikva, Central District, 4941492, Israel

  • Clinical Trial Site

    RECRUITING

    Tel Aviv, Tel Aviv, 6423906, Israel

  • Clinical Trial Site

    RECRUITING

    Haifa, 3109601, Israel

  • Clinical Trial Site

    RECRUITING

    Jerusalem, 91031, Israel

  • Clinical Trial Site

    RECRUITING

    Jerusalem, 91120, Israel

  • Clinical Trial Site

    RECRUITING

    Monza, Monza E Brianza, 20900, Italy

  • Clinical Trial Site

    RECRUITING

    Alessandria, 15121, Italy

  • Clinical Trial Site

    RECRUITING

    Bergamo, 24127, Italy

  • Clinical Trial Site

    RECRUITING

    Bologna, 40138, Italy

  • Clinical Trial Site

    RECRUITING

    Candiolo, 10060, Italy

  • Clinical Trial Site

    RECRUITING

    Florence, 50134, Italy

  • Clinical Trial Site

    RECRUITING

    Meldola, 40-47014, Italy

  • Clinical Trial Site

    RECRUITING

    Milan, 20141, Italy

  • Clinical Trial Site

    RECRUITING

    Milan, 60-20132, Italy

  • Clinical Trial Site

    RECRUITING

    Palermo, 90146, Italy

  • Clinical Trial Site

    RECRUITING

    Pavia, 19-27100, Italy

  • Clinical Trial Site

    RECRUITING

    Perugia, 06132, Italy

  • Clinical Trial Site

    RECRUITING

    Rimini, 47923, Italy

  • Clinical Trial Site

    RECRUITING

    Roma, 00168, Italy

  • Clinical Trial Site

    RECRUITING

    Udine, 15-33100, Italy

  • Clinical Trial Site

    RECRUITING

    Johor Bahru, Johor, 80000, Malaysia

  • Clinical Trial Site

    RECRUITING

    Petaling Jaya, 46050, Malaysia

  • Clinical Trial Site

    RECRUITING

    Subang Jaya, 46150, Malaysia

  • Clinical Trial Site

    RECRUITING

    Târgu Mureş, Mureș County, 540136, Romania

  • Clinical Trial Site

    RECRUITING

    Bucharest, 020125, Romania

  • Clinical Trial Site

    RECRUITING

    Bucharest, 030171, Romania

  • Clinical Trial Site

    RECRUITING

    Cluj-Napoca, 400015, Romania

  • Clinical Trial Site

    RECRUITING

    Iași, 700483, Romania

  • Clinical Trial Site

    RECRUITING

    Busan, Busan Gwang'yeogsi [Pusan-Kwangyokshi], 49201, South Korea

  • Clinical Trial Site

    RECRUITING

    Busan, 48108, South Korea

  • Clinical Trial Site

    RECRUITING

    Goyang-si, 10408, South Korea

  • Clinical Trial Site

    RECRUITING

    Seoul, 03080, South Korea

  • Clinical Trial Site

    RECRUITING

    Seoul, 06591, South Korea

  • Clinical Trial Site

    RECRUITING

    Las Palmas de Gran Canaria, Canary Islands, 35010, Spain

  • Clinical Trial Site

    RECRUITING

    Oviedo, Principality of Asturias, 33011, Spain

  • Clinical Trial Site

    RECRUITING

    Badalona, 08916, Spain

  • Clinical Trial Site

    RECRUITING

    Barcelona, 08036, Spain

  • Clinical Trial Site

    RECRUITING

    Burgos, 09006, Spain

  • Clinical Trial Site

    RECRUITING

    Cáceres, 10003, Spain

  • Clinical Trial Site

    RECRUITING

    Granada, 18014, Spain

  • Clinical Trial Site

    RECRUITING

    Madrid, 28007, Spain

  • Clinical Trial Site

    RECRUITING

    Madrid, 28033, Spain

  • Clinical Trial Site

    RECRUITING

    Madrid, 28034, Spain

  • Clinical Trial Site

    RECRUITING

    Málaga, 29010, Spain

  • Clinical Trial Site

    RECRUITING

    Palma, 07120, Spain

  • Clinical Trial Site

    RECRUITING

    Pamplona, 31008, Spain

  • Clinical Trial Site

    RECRUITING

    Seville, 41013, Spain

  • Clinical Trial Site

    RECRUITING

    Valencia, 46026, Spain

  • Clinical Trial Site

    RECRUITING

    Aberdeen, AB25 2ZN, United Kingdom

  • Clinical Trial Site

    RECRUITING

    Derby, DE22 3NE, United Kingdom

  • Clinical Trial Site

    RECRUITING

    Lincoln, LN2 4AX, United Kingdom

  • Clinical Trial Site

    RECRUITING

    London, W12 0HS, United Kingdom

  • Clinical Trial Site

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

  • Clinical Trial Site 1

    RECRUITING

    Tbilisi, 0159, Georgia

  • Clinical Trial Site 2

    RECRUITING

    Tbilisi, 0159, Georgia

More trials for these conditions

Other studies related to the condition(s) this trial covers.